Vitasora Health Limited has released a press release.
CEO Operational Review
Filed with ASX ·
6ix hasn’t read this filing yet.
Vitasora Health Limited on 6ix
Earlier from Vitasora Health
- Significant Milestone Progress
- Respiri Limited - Functional Prototype Completed
- Respiri limited $3.0m share placement
- Appendix 4D and Interim Financial Report - December 2017
- CEO Update and Reaffirmation of 2018 Plans and Milestones
Later from Vitasora Health
- Appendix 4E and Audited FY2018 Financial Report
- Respiri appoints manufacturing partner
- Appendix 4C and R&D Incentive Announcement
- Trading halt
- $3.2M Share Placement
Follow Vitasora Health into a list and get an email when it puts out news.
Follow Vitasora Health